
CTF Life's Carbon Reduction Targets Validated By Sbti
- Reinforcing the Company's Commitment to Climate Action | ||
HONG KONG, Mar 28, 2025 - (ACN Newswire) - CTF Life announced that its carbon reduction targets have been officially validated by the Science Based Targets initiative (SBTi). The result shows CTF Life's commitment to decarbonisation and provides a set of measurements by which the company's stakeholders can monitor its ongoing efforts. In October last year, CTF Life demonstrated leadership in advancing sustainability through science-based targets aligned with the Paris Agreement and became the first company from the Banks, Diverse Financials and Insurance sector that primarily operates in the Greater Bay Area to submit a carbon reduction commitment letter to the SBTi, a corporate climate action organisation that enables businesses worldwide to play their part in combating the climate crisis. CTF Life targets to reduce absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 37.8% by financial year (FY) 2029 (from the FY2023 base year). Additionally, within its Scope 3 emissions, CTF Life commits the following which covers 65% of its total investment and lending by assets: Man Kit Ip, Executive Director and Chief Executive Officer of CTF Life , said:“At CTF Life, we recognise that climate action is both a critical responsibility and a powerful opportunity to inspire and drive meaningful change. CTF Life has been collaborating closely with CTFS to align our overall Net Zero 2050 ambition; the validation of our targets underscores our unwavering commitment to reducing emissions across our operations and investment portfolio. This milestone reaffirms our dedication to building a sustainable future while creating value beyond insurance for our stakeholders.” CTF Life will implement the following strategy and actions to achieve its targets: Decarbonisation levers for Scope 1 and 2 operational emissions : - Electric vehicles (EV) transition : Replace leased/owned fleet with EVs. Levers for Scope 3 category 15 emissions : - Active ownership and engagement strategy : Implement engagement strategy with a phased approach to facilitate real world reductions. CTF Life selected these actions because the above-mentioned decarbonisation levers are expected to have the most direct impacts on the company's climate transition journey. As of June 2024, the company had already reduced its investment portfolio carbon footprint by more than 15% compared to baseline figures from June 2023. Additionally, CTF Life has invested over HKD3.5 billion in ESG-labelled bonds and decarbonisation impact funds, primarily focused on Asia, to support the region's transition to a greener economy. About CTF Life Chow Tai Fook Life Insurance Company Limited (“CTF Life”) is proud of its rich, 40-year legacy in Hong Kong. CTF Life is a wholly-owned subsidiary of CTF Services Limited (“CTFS”) (Hong Kong Stock Code: 659) and one of the most well-established life insurance companies in Hong Kong. As a member of Chow Tai Fook Enterprises Limited, CTF Life consistently strengthens its collaboration with the diverse conglomerate of the Cheng family (“Chow Tai Fook Group” or“the Group”) to support customers and their loved ones in navigating life's journey with personalised planning solutions, lifelong protection and diverse lifestyle experiences. By leveraging the Group's robust financial strength and strategic investments across the globe, CTF Life aspires to become a leading insurance company in Asia while continuously creating value beyond insurance. Media enquiries
Chow Tai Fook Life Insurance Company Limited (Incorporated in Bermuda with limited liability) |

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment